Head to head comparison of (18F)SiTATE versus (18F])DOPA-PET in patients with neuroendocrine tumors
In neuroendocrine tumors molecular imaging methods play a key role, either targeting the somatostatin receptor or catecholamine pathways. [18F]SiTATE is a somatostatin receptor-targeting peptide that uses silicon fluoride acceptor (SiFA) radiochemistry, overcoming disadvantages of Gallium-68 labelle...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2025
|
| In: |
European journal of nuclear medicine and molecular imaging
|
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-025-07572-w |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00259-025-07572-w |
| Author Notes: | Wolfgang Roll, Panayiotis Hadjitheodorou, Emmanouil Alevroudis, Kyriaki Kyrou, Giorgos Adamou, Andreas Fesas, Björn Wängler, Carmen Wängler, Ralf Schirrmacher, Mohammad R. Pourkhessalian, Charalambia Kalogirou, Ioannis Tsechelidis, Alexis Vrachimis |
| Summary: | In neuroendocrine tumors molecular imaging methods play a key role, either targeting the somatostatin receptor or catecholamine pathways. [18F]SiTATE is a somatostatin receptor-targeting peptide that uses silicon fluoride acceptor (SiFA) radiochemistry, overcoming disadvantages of Gallium-68 labelled DOTA compounds. Here we present the first prospective data of [18F]SiTATE compared to [18F]DOPA-PET in NET patients. |
|---|---|
| Item Description: | Im Titel ist "18F" in eckigen Klammern geschrieben und hochgestellt Online veröffentlicht: 26. September 2025 Gesehen am 30.10.2025 |
| Physical Description: | Online Resource |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-025-07572-w |